Project Grant R01AI199613
Award Date 7/3/26
Completion Date 6/30/31
Dollars Obligated $805K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Columbia, MO 65211, USA
Similar Awards
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $538,501 to the University of Missouri System through the Allergy and Infectious Diseases Research program (CFDA 93.855) on April 1, 2026, for a five-year project extending through March 31, 2031. The project, titled "Aptamer Tools for the Study of HIV Capsid Structure, Function, and Interactions," focuses on developing novel RNA aptamer-based molecular tools to advance...
- Federal Project Grant Award Summary The University of Iowa received a $427,625 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded June 17, 2025, with a completion date of May 31, 2027. This research project investigates the mechanism of measles virus (MEV) transmission in human airway epithelial cells, specifically examining how MEV rapidly forms infectious centers through an...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Washington University a Project Grant totaling $596,115 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective August 1, 2025, with completion targeted for July 31, 2030. This five-year award supports investigator-initiated biomedical research examining the long-term impact of persistent parainfluenza virus infection, specifically focusing on how human...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Washington University a $388,750 Project Grant on July 2, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct basic research on astrovirus pathogenesis. The research focuses on defining the critical functions of the stem-loop II (S2M) motif in the lifecycle of astrovirus VA1, the most common cause of astrovirus encephalitis. Using advanced molecular...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The University of Iowa a $791,990 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) on February 4, 2026, to conduct research investigating the mechanisms underlying measles virus transmission in human airway epithelial cells. The primary research deliverables include fundamental scientific findings regarding infectious center formation and release in...
- Federal Grant Award Summary The University of Montana received a $147,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded April 6, 2026, with completion targeted for March 31, 2028. This R03-mechanism award supports research into inter-strain recombinants of human cytomegalovirus (HCMV) as an in vitro model for studying genetic diversity in infectious pathogens. The project...
- Summary of Federal Project Grant Award The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $149,190 Project Grant to the University of Massachusetts Medical School on December 17, 2025, under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research investigating hemagglutinin-mediated molecular mechanisms of avian influenza A virus host tropism, with completion scheduled for June 30, 2027. The research deliverables focus on...
- Federal Project Grant Award Summary Saint Louis University received a $423,500 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 2, 2026, with a completion date of May 31, 2028. The grant supports research to develop new vaccines against pulmonary Mycobacterium avium complex (MAC) infections using SCNN1B-transgenic mouse models. The project delivers two primary research...
- Federal Project Grant Award Summary The University of Missouri System received a $418,822 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded April 5, 2026, with completion targeted for February 28, 2031. This award supports investigator-initiated basic biomedical research focused on advancing mechanistic understanding of membrane interfaces—specifically, the discovery and...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded The Ohio State University a Project Grant of $433,125 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct basic research on influenza A virus (IAV) pathogenesis and acute respiratory distress syndrome (ARDS) mechanisms. The two-year research initiative, awarded July 2, 2025, and extending through June 30, 2027, investigates how the viral PB1-F2 protein...